Democritus University of Thrace (DUTH)
Design and application of bioactive nanoparticles in cancer prevention and therapy
Abstract
dc:descriptionColorectal cancer is considered a major worldwide health problem with high prevalence and mortality rates. Unfortunately, the scientific progress in the last twenty years has not yet been fully translated into achievements in the clinical practice. Thus, innovative approaches need to be developed and evaluated for utilization of research findings in cancer management. Nanoparticles, a versatile class of materials, represent an effective tool that can be harnessed, facilitating the development of novel biomedical applications in cancer research. Magnetic nanoparticles in particular, have emerged as an important type of functional structures enabling the development of state-of-the art scientific methods due to their ability to be externally controlled. On the other hand, biogenic nanoparticles comprise a different type of nanomaterials that can be synthesized and produced in biological systems. Thus, compared to chemically synthesized nanoparticles, they are more bioavailable, eco-friendly and cost-effective to produce, but, most importantly, biogenic nanoparticles are less toxic. In this dissertation, we employed magnetic nanoparticles with a hydronamic diameter of 100 nm, consisting of a Fe3O4 core coated by a biocompatible starch layer, in order to improve and optimize the transplantable mouse tumor model for the in vivo evaluation of novel anticancer therapeutic strategies. The optimized protocol is based on MNPs-tagged implanted cancer cells that are magnetically manipulated, in order to enable a restricted local growth of tumor cells with the aim to confine the inter-animal variability in tumor volume. Magnetic nanoparticles were employed in order to render CT26 colon cancer cells magnetically responsive before their subcutaneous injection in BALB/c mice. A small magnet was attached on the injection site for the manipulation of the migration pattern of the implanted cells towards localized tumor formation. The in vivo proof-of-principle study was designed to utilize a low-dose of Fluorouracil (5-FU) as a representative anticancer therapy. Although the 5-FU-induced tumor growth inhibition was statistically insignificant in the ‘Control’ group, a statistically significant difference was detected in the ‘Nanoparticles’ group. Remarkably, 60% fewer animals were needed to obtain highly reproducible results when applying the proposed protocol. Furthermore, in colon cancer cells we investigated the growth inhibitory effects of magnetomechanical stress induced by magnetic field-actuated magnetic nanoparticles, employing the same type of biocompatible Fe3O4 nanoparticles as in the previous study. Both static and alternating low frequency magnetic fields with varying intensity (40–200 mT), frequency (0–8 Hz) and field gradient were comparatively studied. Our findings indicate that not only intensity and gradient but also frequency as well as mode of magnetic field affect cellular processes that regulate cell growth. Noteworthy, the optimal static magnetic field of the strongest intensity and gradient (200 mT) that exerted the strongest maximum forces inside cells (29 pN) via the actuation of the internalized nanoparticles, was the field that induced maximum cell growth inhibition. Growth inhibition was not attributed to thermal effects or to cell death but G2/M cell cycle arrest was involved. Moreover, the optimal treatment conditions induced the protein expression of the cell cycle regulators Cyclin B1 and Cyclin D1. Interestingly, internalized nanoparticles were found to preferentially accumulate in the lysosomes, as correlation analysis suggests, and, upon actuation, a significantly reduced number of lysosomes per cell was detected. Finally, we produced biogenic dietary selenium nanoparticles that exhibited excellent cancer-specific antiproliferative properties against colon cancer in vitro as well as significant tumor growth suppression in vivo. The probiotic strain Lactobacillus casei ATCC 393 was utilized to synthesize nanoparticles, which i) contain amorphous selenium, ii) are of spherical shape and iii) have a mean diameter of 360 nm. Our findings suggest that, in contrast to L. casei, purified SeNps or SeNps-enriched L. casei exhibited cancer-specific antiproliferative activities against colon cancer cells. Specifically, SeNps induced G1/G0 cell cycle arrest in both CT26 and HT29 cells. Moreover, in HT29 cells, SeNps pronouncedly upregulated the expression of certain pro-apoptotic proteins, such as TNFR1, Bax and the TRAIL death receptors DR4 and DR5, while they inhibited the expression of various apoptosis inhibitors, such as Survivin, Livin, cIAP1 and cIPA2. Crucially, orally administered SeNps-enriched L. casei generated the strongest tumor growth suppression (-77% reduction in tumor volume) compared to wild-type L. casei or SeNps: the latter two induced similar rates of tumor growth inhibition (-54% and -48%, respectively) in the experimental CT26 mouse tumor model. Future investigations may further characterize the underlying molecular mechanisms and broaden the application spectrum of the proposed novel protocols and procedures. Τhe applicability of the described nanoparticle-based scientific work in these different cancer research areas though, demonstrates the potential of cancer biotechnology to harness nanoparticles and revolutionize the field.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spyridopoulou, Katerina
- Σπυριδοπούλου, Αικατερίνη
Subjects
dc:subject × 10Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44954